MEA Collateral Ligament Stabilizer System Market

The size of the Middle East and Africa Collateral Ligament Stabilizer System market was around USD 0.18 billion in 2022. It is expected to grow at a CAGR of 7.213% to reach USD 0.26 billion by 2027.

The number of patients who have arthritis and joint disorders is studied to increase due to the steady aging of the population, contributing towards the growth of the MEA collateral ligament stabilizer system market. The growing incidence of sports-related injuries from baseball, football, rugby, and others, causes ligament tears, valgus knee stacking, muscle sprains, and bone fractures. In addition, the increase in traffic accidents will drive the demand for this market. According to the World Health Organization (WHO), each year, nearly 10 million people are injured or disabled due to traffic accidents. People who had traffic accidents use knee braces and pain management support, which increases the demand and adoption of these products. According to the Stanford Children's Health Report, approximately 3.54 million sports injuries occur annually.

Ligament damage is also caused by musculoskeletal conditions such as tarsal tunnel syndrome and Raynaud's syndrome. For example, according to World Health Organization reports released in 2019, musculoskeletal disorder is responsible for weakness and injury to collateral ligaments, which drives the market's growth. Furthermore, people with low calcium density are more prone to osteoporosis and osteomalacia, and they require collateral ligament stabilizers to avoid sprains and fractures. Moreover, the growing technological advancements and the prevalence of favorable government reimbursement policies will offer more opportunities for the growth of the MEA collateral ligament stabilizer system market during the aforementioned forecast period.

However, the factor that is expected to restrain the growth of the MEA collateral ligament stabilizer system market is the high cost associated with product use. Secondly, the lack of reimbursement policies for these products is expected to challenge the market growth during the forecast period.

This research report on the Middle East and Africa collateral ligament stabilizer market has been segmented & sub-segmented into the following categories:

By Ligament Type:

• Medial Collateral Ligament (MCL) 
• Lateral Collateral Ligament (LCL)   

By Injury Type:

• Grade 1 Injury       
• Grade 2 Injury       
• Grade 3 Injury       

By End Use:

• Hospitals  
• Orthopedic Clinics

By Country:

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

Geographically, Saudi Arabia dominates the MEA market due to encouraging reimbursement policies, the number of older people, the presence of key market players in the region, and the high incidence of knee injuries in sports and accidents. According to World Health Organization reports, musculoskeletal disorders rank second in the Eastern Mediterranean region and third in Africa. The prevalence of osteoporosis and osteopenia in Saudi Arabia is about 37.8% and 28.2% in men and women above 50 years, respectively.

The regional market in the United Arab Emirates is studied to account for the highest growth in the MEA collateral ligament stabilizer system market during the prognostic period followed by South Africa. The market will be significantly boosted owing to an increase in medical expenditures, improved healthcare facilities, increased sports injuries, and an increase in an elderly population.

The market in Egypt is driven by rising incomes and the increasing prevalence of osteoarthritis. This region has a plethora of untapped opportunities with the rising prevalence of chronic diseases, an increase in the number of accident and trauma cases, and ongoing R&D activities by major market players are studied to produce innovative products that stimulate the market growth over the forecast period.

KEY MARKET PLAYERS:

Some of the major manufacturers of the CLSS market include DJO Global LLC, DePuy Synthes, Ossur, DeRoyal Industries, Bauerfeind, Seabourne Group, Arthrex, and Deroyal.